These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 26513047)

  • 1. Reversible skin hypopigmentation after topical application of high potency glucocorticosteroids.
    Piraccini BM; Gurioli C; Bruni F; Patrizi A
    G Ital Dermatol Venereol; 2015 Dec; 150(6):759-61. PubMed ID: 26513047
    [No Abstract]   [Full Text] [Related]  

  • 2. Clobetasol propionate, 0.05%, vs hydrocortisone, 1%, for alopecia areata in children: a randomized clinical trial.
    Lenane P; Macarthur C; Parkin PC; Krafchik B; DeGroot J; Khambalia A; Pope E
    JAMA Dermatol; 2014 Jan; 150(1):47-50. PubMed ID: 24226568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of segmental vitiligo to 0.05% clobetasol propionate cream.
    Khalid M; Mujtaba G
    Int J Dermatol; 1998 Sep; 37(9):705-8. PubMed ID: 9762827
    [No Abstract]   [Full Text] [Related]  

  • 4. Retronychia in children, adolescents, and young adults: a case series.
    Piraccini BM; Richert B; de Berker DA; Tengattini V; Sgubbi P; Patrizi A; Stinchi C; Savoia F
    J Am Acad Dermatol; 2014 Feb; 70(2):388-90. PubMed ID: 24438963
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the topical FK506 and clobetasol propionate as first-line therapy in the treatment of early alopecia areata.
    Jung KE; Gye JW; Park MK; Park BC
    Int J Dermatol; 2017 Dec; 56(12):1487-1488. PubMed ID: 28703306
    [No Abstract]   [Full Text] [Related]  

  • 6. [Emovate in pediatric practice. A Swiss study on a new local corticosteroid].
    Graber W; Miescher A; Schneider HJ
    Ther Umsch; 1983 May; 40(5):449-53. PubMed ID: 6346567
    [No Abstract]   [Full Text] [Related]  

  • 7. Guidelines for using superpotent topical steroids.
    Prawer SE; Katz HI
    Am Fam Physician; 1990 May; 41(5):1531-8. PubMed ID: 2333829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis.
    Tosti A; Piraccini BM; Pazzaglia M; Vincenzi C
    J Am Acad Dermatol; 2003 Jul; 49(1):96-8. PubMed ID: 12833016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc aspartate, biotin, and clobetasol propionate in the treatment of alopecia areata in childhood.
    Camacho FM; García-Hernández MJ
    Pediatr Dermatol; 1999; 16(4):336-8. PubMed ID: 10515774
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of clobetasol propionate cream plus coal tar vs. topical psoralen and solar ultraviolet A therapy in palmoplantar psoriasis.
    Khandpur S; Sharma VK
    Clin Exp Dermatol; 2011 Aug; 36(6):613-6. PubMed ID: 21507036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clobetasol propionate lotion in the treatment of moderate to severe plaque-type psoriasis.
    Decroix J; Pres H; Tsankov N; Poncet M; Arsonnaud S
    Cutis; 2004 Sep; 74(3):201-6. PubMed ID: 15499763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo.
    Lepe V; Moncada B; Castanedo-Cazares JP; Torres-Alvarez MB; Ortiz CA; Torres-Rubalcava AB
    Arch Dermatol; 2003 May; 139(5):581-5. PubMed ID: 12756094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuropsychiatric disorders due to clobetasol propionate misuse].
    Law Ping Man L; Poreaux C; Cuny JF; Javot L; Petitpain N; Barbaud A; Schmutz JL
    Therapie; 2013; 68(3):179-81. PubMed ID: 23886466
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined oral pulse and topical corticosteroid therapy for severe alopecia areata in children: a long-term follow-up study.
    Lalosevic J; Gajic-Veljic M; Bonaci-Nikolic B; Nikolic M
    Dermatol Ther; 2015; 28(5):309-17. PubMed ID: 26179196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clobetasol propionate spray 0.05% for the treatment of moderate to severe plaque psoriasis.
    Menter A
    Cutis; 2012 Feb; 89(2):89-94. PubMed ID: 22474733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial.
    Tosti A; Iorizzo M; Botta GL; Milani M
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1243-7. PubMed ID: 17062039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clobetasol propionate 0.05% under occlusion for alopecia areata: Clinical effect and influence on intraocular pressure.
    Nomiyama T; Katoh N
    Australas J Dermatol; 2021 May; 62(2):e262-e264. PubMed ID: 33393075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clobetasol propionate shampoo 0.05%: a new option to treat patients with moderate to severe scalp psoriasis.
    Jarratt M; Breneman D; Gottlieb AB; Poulin Y; Liu Y; Foley V
    J Drugs Dermatol; 2004; 3(4):367-73. PubMed ID: 15303780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe sorafenib-induced hand-foot skin reaction.
    Cuesta L; Betlloch I; Toledo F; Latorre N; Monteagudo A
    Dermatol Online J; 2011 May; 17(5):14. PubMed ID: 21635836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scaly plaque with pustules and anonychia on the middle finger.
    Chandra JA; Rajpara A; Blackmon J
    Cutis; 2015 Dec; 96(6):E1-2. PubMed ID: 26761938
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.